Stocks
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -189.4 | -250.9 | -328.3 | -374.8 | -427.4 | -396.4 | ||
| Changes by years, y/y, % | +48% | +32% | +31% | +14% | +14% | +27.2% | |||
Iovance Biotherapeutics. EBITDA US GAAP, bln rub
Iovance Biotherapeutics. EBITDA US GAAP, changes, %
Iovance Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -105.1 | -108.4 | -107.8 | -91.1 | -89.1 | -396.4 | |
| Changes by years, y/y, % | +5% | +1% | -3% | -17% | -15% | |||
| Changes by quarters, q/q, % | -5% | +3% | -1% | -16% | -2% | |||
